| Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options J Jankowski, J Floege, D Fliser, M Böhm, N Marx Circulation 143 (11), 1157-1172, 2021 | 1294 | 2021 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1270 | 2012 |
| The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification C Schäfer, A Heiss, A Schwarz, R Westenfeld, M Ketteler, J Floege, ... The Journal of clinical investigation 112 (3), 357-366, 2003 | 1260 | 2003 |
| Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study M Ketteler, P Bongartz, R Westenfeld, JE Wildberger, AH Mahnken, ... The Lancet 361 (9360), 827-833, 2003 | 1247 | 2003 |
| Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis EVOLVE Trial Investigators New England Journal of Medicine 367 (26), 2482-2494, 2012 | 1057 | 2012 |
| Intensive supportive care plus immunosuppression in IgA nephropathy T Rauen, F Eitner, C Fitzner, C Sommerer, M Zeier, B Otte, U Panzer, ... New England Journal of Medicine 373 (23), 2225-2236, 2015 | 721 | 2015 |
| The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis P Raggi, GM Chertow, PU Torres, B Csiky, A Naso, K Nossuli, M Moustafa, ... Nephrology Dialysis Transplantation 26 (4), 1327-1339, 2011 | 712 | 2011 |
| Renal fibrosis: novel insights into mechanisms and therapeutic targets P Boor, T Ostendorf, J Floege Nature Reviews Nephrology 6 (11), 643-656, 2010 | 703 | 2010 |
| Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population J Floege, J Kim, E Ireland, C Chazot, T Drueke, A de Francisco, ... Nephrology Dialysis Transplantation 26 (6), 1948-1955, 2011 | 698 | 2011 |
| Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens K Kiryluk, Y Li, F Scolari, S Sanna-Cherchi, M Choi, M Verbitsky, D Fasel, ... Nature genetics 46 (11), 1187-1196, 2014 | 669 | 2014 |
| Renal injury from angiotensin II-mediated hypertension. RJ Johnson, CE Alpers, A Yoshimura, D Lombardi, P Pritzl, J Floege, ... Hypertension 19 (5), 464-474, 1992 | 653 | 1992 |
| KDIGO 2021 clinical practice guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), S1-S276, 2021 | 588 | 2021 |
| Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), 753-779, 2021 | 571 | 2021 |
| Recruitment of podocytes from glomerular parietal epithelial cells D Appel, DB Kershaw, B Smeets, G Yuan, A Fuss, M Elger, W Kriz, ... Journal of the American Society of Nephrology 20 (2), 333-343, 2009 | 536 | 2009 |
| Decoding myofibroblast origins in human kidney fibrosis C Kuppe, MM Ibrahim, J Kranz, X Zhang, S Ziegler, J Perales-Patón, ... Nature 589 (7841), 281-286, 2021 | 519 | 2021 |
| Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial J Lv, H Zhang, MG Wong, MJ Jardine, M Hladunewich, V Jha, ... Jama 318 (5), 432-442, 2017 | 508 | 2017 |
| Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model J Floege, MW Burns, CE Alpers, A Yoshimura, P Pritzl, K Gordon, ... Kidney international 41 (2), 297-309, 1992 | 487 | 1992 |
| Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments R Coppo, S Troyanov, S Bellur, D Cattran, HT Cook, J Feehally, ... Kidney international 86 (4), 828-836, 2014 | 462 | 2014 |
| Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes TM Coimbra, U Janssen, HJ Gröne, T Ostendorf, U Kunter, H Schmidt, ... Kidney international 57 (1), 167-182, 2000 | 448 | 2000 |
| Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. RJ Johnson, EW Raines, J Floege, A Yoshimura, P Pritzl, C Alpers, ... The Journal of experimental medicine 175 (5), 1413-1416, 1992 | 429 | 1992 |
